These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5774314)

  • 21. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial split vaccines.
    Schwick HG; Helting TB; Zwisler O
    Prog Clin Biol Res; 1980; 47():143-55. PubMed ID: 6259662
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphtheria-tetanus-pertussis immunization by intradermal jet injection.
    Stanfield JP; Bracken PM; Waddell KM; Gall D
    Br Med J; 1972 Apr; 2(5807):197-9. PubMed ID: 5022729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of mixed diphtheria-pertussis-tetanus antigens.
    COCKBURN WC
    Bull World Health Organ; 1955; 13(3):409-22. PubMed ID: 13270080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-dose schedule for immunization of infants using a more concentrated DPT-vaccine.
    Mangay-Angara A; Fulgencio L; Casabal G; Gudani L; Sumpaico J; Ocampo A; Nagel J; Hagenaars AM; van Hemert PA; Cohen H
    Dev Biol Stand; 1978; 41():15-22. PubMed ID: 753647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    JAMA; 1985 Aug 23-30; 254(8):1009-11, 1014-6. PubMed ID: 3874970
    [No Abstract]   [Full Text] [Related]  

  • 31. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule.
    Barkin RM; Samuelson JS; Gotlin LP
    Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(27):405-14, 419-26. PubMed ID: 3925316
    [No Abstract]   [Full Text] [Related]  

  • 33. Diphtheria, tetanus, and pertussis immunizations in adults.
    Edwards KM
    Infect Dis Clin North Am; 1990 Mar; 4(1):85-103. PubMed ID: 2407780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LABORATORY EVALUATION OF IMMUNOGENIC PROPERTIES OF NON-ADSORBED TRI-VACCINE DI-TE-PER PRODUCED IN POLAND. THE TETANUS COMPONENT].
    SZULKIN E; SPORSZYNSKA Z; KUDELSKI Z
    Med Dosw Mikrobiol; 1964; 16():111-22. PubMed ID: 14203987
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with combined diptheria and tetanus toxoids (aluminum hydroxide adsorbed) containing H. pertussis vaccine. The duration of serologic immunity.
    MILLER JJ; RYAN ML
    Pediatrics; 1948 Jan; 1(1):8-22. PubMed ID: 18905779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.